<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37013139</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1535</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Hepatic medicine : evidence and research</Title><ISOAbbreviation>Hepat Med</ISOAbbreviation></Journal><ArticleTitle>COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>32</EndPage><MedlinePgn>27-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/HMER.S384176</ELocationID><Abstract><AbstractText>The complete impact of COVID-19 infection continues to develop since the onset of the COVID-19 pandemic. COVID-19 cholangiopathy has been recently described in a subset of patients who recovered from severe COVID-19 infection. The most common phenotype of patients suffering from COVID-19 cholangiopathy had severe infection requiring a stay in the intensive care unit, mechanical ventilation and vasopressor medications. Patients with COVID-cholangiopathy present with severe and prolonged cholestatic liver injury. In cases where biliary cast formation is identified, we defined the entity as "COVID-19 cast-forming cholangiopathy". This subset of COVID-19 cholangiopathy is not well understood and there are no standardized diagnosis or management to this date. The reported clinical outcomes are variable, from resolution of symptoms and liver test abnormalities to liver transplant and death. In this commentary, we discuss the proposed pathophysiology, diagnosis, management, and prognosis of this disease.</AbstractText><CopyrightInformation>&#xa9; 2023 Sarkis et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sarkis</LastName><ForeName>Yara</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleem</LastName><ForeName>Nasir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuppalanchi</LastName><ForeName>Raj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gromski</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9035-2434</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Hepat Med</MedlineTA><NlmUniqueID>101544801</NlmUniqueID><ISSNLinking>1179-1535</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 cholangiopathy</Keyword><Keyword MajorTopicYN="N">COVID-19 infection</Keyword><Keyword MajorTopicYN="N">cast-forming cholangiopathy</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword></KeywordList><CoiStatement>Yara Sarkis and Nasir Saleem are co-primary authors. Dr Mark Gromski is a consultant for Boston Scientific, received research support from Olympus and Cook Medical, outside the submitted work; None of the authors disclose a conflict of interest relative to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>2</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37013139</ArticleId><ArticleId IdType="pmc">PMC10066716</ArticleId><ArticleId IdType="doi">10.2147/HMER.S384176</ArticleId><ArticleId IdType="pii">384176</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saleem N, Li BH, Vuppalanchi R, Gawrieh S, Gromski MA. Critical illness cholangiopathy in COVID-19 long-haulers. Tech Innov Gastrointest Endosc. 2022;24:351&#x2013;353. doi:10.1016/j.tige.2022.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tige.2022.05.006</ArticleId><ArticleId IdType="pmc">PMC9123802</ArticleId><ArticleId IdType="pubmed">35615695</ArticleId></ArticleIdList></Reference><Reference><Citation>Faruqui S, Okoli FC, Olsen SK, et al. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol. 2021;116(7):1414&#x2013;1425. doi:10.14309/ajg.0000000000001264</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001264</ArticleId><ArticleId IdType="pubmed">33993134</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077&#x2013;1082. doi:10.14309/ajg.0000000000001154</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley JE. Editorial: COVID-19 - the long road to recovery. J Nutr Health Aging. 2020;24(9):917&#x2013;919. doi:10.1007/s12603-020-1473-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-020-1473-6</ArticleId><ArticleId IdType="pmc">PMC7597432</ArticleId><ArticleId IdType="pubmed">33155615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemmers A, Pezzullo M, Hadefi A, et al. Biliary cast syndrome after liver transplantation: a cholangiographic evolution study. J Gastroenterol Hepatol. 2021;36(5):1366&#x2013;1377. doi:10.1111/jgh.15318</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15318</ArticleId><ArticleId IdType="pubmed">33150992</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent L, Lemaitre C, Minello A, et al. Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units. Aliment Pharmacol Ther. 2017;46(11&#x2013;12):1070&#x2013;1076. doi:10.1111/apt.14367</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14367</ArticleId><ArticleId IdType="pubmed">29023905</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelbmann CM, R&#xfc;mmele P, Wimmer M, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol. 2007;102(6):1221&#x2013;1229. doi:10.1111/j.1572-0241.2007.01118.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2007.01118.x</ArticleId><ArticleId IdType="pubmed">17531010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoli A, Cursaro C, Andreone P. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies. Curr Opin Gastroenterol. 2022;38(2):89&#x2013;97. doi:10.1097/MOG.0000000000000808</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000808</ArticleId><ArticleId IdType="pmc">PMC8815639</ArticleId><ArticleId IdType="pubmed">35098930</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldera J, Balbinot RA, Balbinot SS. Billiary casts in post-COVID-19 cholangiopathy. Gastroenterol Hepatol. 2022. doi:10.1016/j.gastrohep.2022.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastrohep.2022.08.008</ArticleId><ArticleId IdType="pmc">PMC9476357</ArticleId><ArticleId IdType="pubmed">36116722</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaliwal A, Dhindsa BS, Esquivel RG. COVID bile duct: biliary cast syndrome as a complication of SARS-CoV-2 infection. J Gastrointest Surg off J Soc Surg Aliment Tract. 2022;26(8):1806&#x2013;1807. doi:10.1007/s11605-022-05297-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-022-05297-x</ArticleId><ArticleId IdType="pmc">PMC8926087</ArticleId><ArticleId IdType="pubmed">35296958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni AV, Khlegi A, Sekaran A, et al. Post COVID-19 cholestasis: a case series and review of literature. J Clin Exp Hepatol. 2022;12:1580&#x2013;1590. doi:10.1016/j.jceh.2022.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jceh.2022.06.004</ArticleId><ArticleId IdType="pmc">PMC9187855</ArticleId><ArticleId IdType="pubmed">35719861</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Alvarado J, Zavaleta Corvera C, Merino Bacilio B, Ruiz Caballero C, Lozano-Peralta K. Post-COVID cholangiopathy: a narrative review. Gastroenterol Hepatol. 2022. doi:10.1016/j.gastrohep.2022.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastrohep.2022.09.004</ArticleId><ArticleId IdType="pmc">PMC9512521</ArticleId><ArticleId IdType="pubmed">36174796</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1&#x2013;9. doi:10.1002/rmv.2141</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunyady P, Streller L, R&#xfc;ther DF, et al. Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study. Clin Infect Dis off Publ Infect Dis Soc Am. 2022. doi:10.1093/cid/ciac565</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac565</ArticleId><ArticleId IdType="pmc">PMC9278244</ArticleId><ArticleId IdType="pubmed">35809032</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethineedi LD, Suvvari TK. Post COVID-19 cholangiopathy - A deep dive. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2021;53(10):1235&#x2013;1236. doi:10.1016/j.dld.2021.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2021.08.001</ArticleId><ArticleId IdType="pmc">PMC8349694</ArticleId><ArticleId IdType="pubmed">34412993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendel-Garcia PD, Erlebach R, Hofmaenner DA, et al. Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome. Crit Care Lond Engl. 2022;26(1):148. doi:10.1186/s13054-022-04019-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04019-8</ArticleId><ArticleId IdType="pmc">PMC9125956</ArticleId><ArticleId IdType="pubmed">35606831</ArticleId></ArticleIdList></Reference><Reference><Citation>Linneweber L, Mann AB, Denk G, Kraft E, Weber S. Cholangiopathy in early rehabilitation after intensive care treatment of patients with COVID-19. Am J Gastroenterol. 2022;117(1):197&#x2013;198. doi:10.14309/ajg.0000000000001511</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001511</ArticleId><ArticleId IdType="pubmed">34585676</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafreshi S, Whiteside I, Levine I, D&#x2019;Agostino C. A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging. 2021;80:239&#x2013;242. doi:10.1016/j.clinimag.2021.07.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2021.07.017</ArticleId><ArticleId IdType="pmc">PMC8314797</ArticleId><ArticleId IdType="pubmed">34364072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rela M, Rajakannu M, Veerankutty FH, Vij M, Rammohan A. First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection. Am J Transplant off J Am Soc Transplant Am Soc Transpl Surg. 2022;22(12):3143&#x2013;3145. doi:10.1111/ajt.17165</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.17165</ArticleId><ArticleId IdType="pmc">PMC9538267</ArticleId><ArticleId IdType="pubmed">35929565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep. 2021;14:8. doi:10.1136/bcr-2021-244168</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244168</ArticleId><ArticleId IdType="pmc">PMC8395362</ArticleId><ArticleId IdType="pubmed">34446515</ArticleId></ArticleIdList></Reference><Reference><Citation>Klindt C, Jensen BE, Brandenburger T, et al. Secondary sclerosing cholangitis as a complication of severe COVID-19: a case report and review of the literature. Clin Case Rep. 2021;9(5):e04068. doi:10.1002/ccr3.4068</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4068</ArticleId><ArticleId IdType="pmc">PMC8142800</ArticleId><ArticleId IdType="pubmed">34084492</ArticleId></ArticleIdList></Reference><Reference><Citation>Durazo FA, Nicholas AA, Mahaffey JJ, et al. Post-covid-19 cholangiopathy-A new indication for liver transplantation: a case report. Transplant Proc. 2021;53(4):1132&#x2013;1137. doi:10.1016/j.transproceed.2021.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC7953456</ArticleId><ArticleId IdType="pubmed">33846012</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersseman P, Blondeel J, De Vlieger G, van der Merwe S, Monbaliu D; Collaborators Leuven Liver Transplant program. Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients. Intensive Care Med. 2021;47(9):1037&#x2013;1040. doi:10.1007/s00134-021-06445-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06445-8</ArticleId><ArticleId IdType="pmc">PMC8239331</ArticleId><ArticleId IdType="pubmed">34185115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>